U.S. markets open in 6 hours 22 minutes
  • S&P Futures

    3,816.50
    -22.50 (-0.59%)
     
  • Dow Futures

    31,411.00
    -54.00 (-0.17%)
     
  • Nasdaq Futures

    12,474.25
    -189.50 (-1.50%)
     
  • Russell 2000 Futures

    2,178.30
    -11.40 (-0.52%)
     
  • Crude Oil

    66.93
    +0.84 (+1.27%)
     
  • Gold

    1,696.20
    -2.30 (-0.14%)
     
  • Silver

    25.39
    +0.10 (+0.39%)
     
  • EUR/USD

    1.1896
    -0.0028 (-0.24%)
     
  • 10-Yr Bond

    1.5540
    0.0000 (0.00%)
     
  • Vix

    24.66
    -3.91 (-13.69%)
     
  • GBP/USD

    1.3839
    +0.0011 (+0.08%)
     
  • USD/JPY

    108.4230
    +0.0410 (+0.04%)
     
  • BTC-USD

    49,819.41
    +374.36 (+0.76%)
     
  • CMC Crypto 200

    1,007.16
    +63.99 (+6.78%)
     
  • FTSE 100

    6,630.52
    0.00 (0.00%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

EIDX ALERT - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ: EIDX) for Potential Securities Violations and Breach of Fiduciary Duty

·1 min read

NEW YORK, NY / ACCESSWIRE / December 16, 2020 / Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against clinical-stage biotech company Eidos Therapeutics. (NASDAQ:EIDX).

If you currently own shares of Eidos and want to receive additional information and protect your investments free of charge, please contact David J. Schwartz using the toll free number (800) 321-0476 or via email at dschwartz@labaton.com.

About the Firm
Labaton Sucharow LLP is one of the world's leading complex litigation firms representing clients in securities, antitrust, corporate governance and shareholder rights, and consumer cybersecurity and data privacy litigation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at http://www.labaton.com.

Contact
David J. Schwartz
(800) 321-0476
dschwartz@labaton.com

SOURCE: Labaton Sucharow LLP



View source version on accesswire.com:
https://www.accesswire.com/621151/EIDX-ALERT--Shareholder-Rights-Firm-Labaton-Sucharow-is-Investigating-Eidos-Therapeutics-NASDAQ-EIDX-for-Potential-Securities-Violations-and-Breach-of-Fiduciary-Duty